2016
DOI: 10.1002/marc.201600189
|View full text |Cite
|
Sign up to set email alerts
|

Polymeric Thioxanthones as Potential Anticancer and Radiotherapy Agents

Abstract: Thioxanthone (TX) and its derivatives, which are widely used as photoinitiators in UV curing technology, hold promising research interest in biological applications. In particular, the use of TXs as anticancer agent has recently been manifested as an outstanding additional property of this class of molecules. Incorporation of TX molecules into specially designed polymers widens their practical use in such applications. In this study, two water-soluble, biocompatible, and stable polymers, namely poly(vinyl alco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 42 publications
(85 reference statements)
0
8
0
Order By: Relevance
“…Radiating the thioxanthone-polyethylene glycol material with 2.5 Gy exposure drastically decreased the A549 cell viability percentage to 30%. This research offers an option for the usage of low solubility xanthone and/or thioxanthone derivatives for in vivo and clinical uses [213]. In contrast to the reports on the clinical study of α-mangostin and DMXAA that are available now, the reports on both in vivo and clinical study of other xanthone derivatives are very limited.…”
Section: In Vivo and Clinical Anticancer Assays Of Xanthone Derivativesmentioning
confidence: 99%
“…Radiating the thioxanthone-polyethylene glycol material with 2.5 Gy exposure drastically decreased the A549 cell viability percentage to 30%. This research offers an option for the usage of low solubility xanthone and/or thioxanthone derivatives for in vivo and clinical uses [213]. In contrast to the reports on the clinical study of α-mangostin and DMXAA that are available now, the reports on both in vivo and clinical study of other xanthone derivatives are very limited.…”
Section: In Vivo and Clinical Anticancer Assays Of Xanthone Derivativesmentioning
confidence: 99%
“…TX‐A was prepared according to a known procedure . Typically 1.0 g thiosalicylic acid (6.49 mmol, 1 eq) was added to 40 mL concentrated sulfuric acid and stirred for 10 min.…”
Section: Methodsmentioning
confidence: 99%
“…Different thiol, hydroxy, amine, aldehyde, and carboxylic acid derivatives of TX were reported in the past as effective one‐component photoinitiating systems and their initiation mechanism was elucidated. Recently, polymeric and polymerizable TX photoinitiators showed excellent performance in initiating polymerization reactions in the absence of co‐initiators, thus minimizing the risk of leaching . Furthermore, the absorption properties of TX could be shifted to the near UV and visible spectrum by incorporating polynuclear aromatic moieties such as anthracene, fluorene, and carbazole in the structure while keeping up the one‐component characteristics of the initiator .…”
Section: Introductionmentioning
confidence: 99%
“…Remarkably, the utilization of PSAs for siRNA delivery to a desired area is of great importance in order to overcome a possible radiation resistance. 246 Among different PSAs, the chitosan-based nanocomposite is an outstanding one because this biopolymer can easily maintain its structural integrity before being exposed to the acidic media of cancerous cells.…”
Section: Polysaccharide Nanocomposites For Cancer Diagnosis and Treat...mentioning
confidence: 99%